In a regulatory filing, HCA Healthcare (HCA) chief ethics officer Kathleen Whalen disclosed the sale of 1,474 common shares of the company on November 14 at a price of $357.99 per share.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $392 from $396 at Barclays
- HCA Healthcare price target raised to $400 from $395 at Wells Fargo
- HCA Healthcare price target raised to $400 from $390 at Oppenheimer
- HCA Healthcare price target lowered to $440 from $450 at TD Cowen
- HCA Healthcare price target lowered to $406 from $427 at Morgan Stanley